孕激素治疗威胁流产和不明原因的重复妊娠流产:泰国利益集团的建议
Kiattisak Kongwattanakul1, Phudit Jatavan2, Olarik Musigavong3
1Maternal Fetal Medicine Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
The journal of obstetrics and gynaecology research
|August 13, 2025
概括
这项研究为泰国医疗保健提供了基于证据的建议,用于使用孕激素补充剂来管理威胁流产和不明原因的重复妊娠丧失 (RPL). 这些指导方针旨在改善患者的治疗结果,并为面临这些困难条件的妇女提供标准的护理.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 临床指南 临床指南
背景情况:
- 流产的威胁和无法解释的重复妊娠损失 (RPL) 构成了全球重大健康挑战.
- 泰国管理不一致的原因是缺乏当地指导方针和不同的国际建议.
- 孕激素补充剂是这些疾病的关键治疗考虑因素.
研究的目的:
- 为泰国医疗保健提供者制定基于证据的推,用于孕激素补充在威胁流产和不明原因的RPL中.
- 解决泰国内部对标准化管理协议的需求.
- 为了指导各种孕激素配方的有效使用.
主要方法:
- 对现有的国际指导方针和相关科学研究进行全面审查.
- 基于证据的分析,以界定诊断和治疗策略.
- 泰国利益集团制定建议.
主要成果:
- 在两次或更多次流产后,建议对不明原因的RPL进行治疗.
- 口服二二推用于威胁流产和无法解释的RPL.
- 提供了微化阴道孕激素 (MVP) 和注射性孕激素的具体剂量和使用指南,并讨论了安全性考虑.
结论:
- 这些是第一个基于证据的泰国建议,用于管理威胁流产和不明原因的RPL.
- 这些指南旨在在区域医疗保健机构中应用,以改善患者的治疗结果.
- 建议进行进一步的研究,以了解泰国这些疾病的特定流行病学和病因学.
更多相关视频
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
10.1K
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
1.4K
相关概念视频
01:19Mitral Valve Prolapse III: Nursing Management
36
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
01:27Ovarian Cycle
1.9K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.9K